Cryo-Save logo CryoSave

Investor
Relations

Speak to an expert! Call us on +971 509196115!

Cryo-Save, the leading international stem cell storage brand and the largest family stem cell bank in Europe, is an established healthcare services group which focuses on the collection, processing and storage of human adult stem cells. Cryo-Save has already stored more than 300,000 samples from umbilical cord blood and umbilical cord tissue.

Cryo-Save is listed on NYSE Euronext Amsterdam (ticker: CRYO) and is a profitable, cash generative business, which pays a dividend. Cryo-Save has a highly scalable business model with significant operational gearing.

In being the leading international family stem cell bank, Cryo-Save recognises its responsibility to proactively contribute to building knowledge and expertise in adult stem cell applications and research. Cryo-Save’s educational program aims to increase global awareness of stem cell therapy and the potential of regenerative medicine amongst healthcare professionals and local communities. This education provides the fundamentals for Cryo-Save’s sustainable growth; increasing both market size and market share in existing markets.